Learn more at noom.com, subscribe to our blog, or follow us on Twitter and LinkedIn
Although GLP-1 receptor agonists have demonstrated effectiveness in reducing weight loss and risks for other chronic diseases, questions remain over whether the benefits outweigh the harms of the drugs, including their cost-effectiveness and economic impact, Hannah Moll, a PhD candidate from the department of epidemiology at the University of Zurich in Switzerland, and colleagues, wrote in eClinicalMedicine
For latest trials, check clinicaltrials.gov
119 (6): 68593 Kaiser HJ, Flammer J, Wenk M, et al
Observe any variations or trends in GPx activity among your samples
Summary: Evidence for using inositol and berberine together specifically for weight loss is limited, with most studies examining each supplement individually rather than in combination